<DOC>
	<DOCNO>NCT00761670</DOCNO>
	<brief_summary>Primary objective - To compare neurocognitive effect amisulpride risperidone patient chronic schizophrenia , assess general cognitive index , measure overall cognitive functioning schizophrenia Secondary objectives - Secondary analysis conduct determine two atypical agent ' neurocognitive effect compare regard profile therapeutic action ( base individual cognitive domain score seven cognitive domain , include speed processing , attention/vigilance , work memory , verbal learn memory , visual learn memory , reason problem solve social cognition ) ; - Investigate whether amisulpride elicits improvement negative symptom compare risperidone treatment , measure total score Scale Assessment Negative Symptoms ( SANS ) 8 Negative Symptom Subscale Positive Negative Symptom Scale ( PANSS ) ; - Assess whether amisulpride improves overall function individual domain psychotic symptom compare risperidone measure Clinical Global Impression ( CGI ) , total positive general psychopathology subscale score PANSS individual domain SANS , respectively ; - Evaluate safety tolerability amisulpride risperidone base study completion rate , frequency abnormal laboratory value , prolactin serum concentration Simpson Angus Scale Extrapyramidal Symptoms ( SAS ) 10 Abnormal Involuntary Movement Scale ( AIMS ) .</brief_summary>
	<brief_title>Efficacy Study Cognitive Functions Schizophrenic Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Sultopride</mesh_term>
	<mesh_term>Sulpiride</mesh_term>
	<criteria>Diagnosis : DSMIV schizophrenia ( subtype ) Duration illness : â‰¥ 5 year Concomitant stand prn medication ( except antipsychotic contraindicate respective package insert [ amisulpride risperidone ] ) permit treatment phase , present stable dose least 6 week prior start initial treatment study medication Overall symptom severity : patient must evidence total score 60 high PANSS scale Clinical Symptoms : A score 4 ( moderate ) great 7 item PANSS Positive Symptom Subscale present Cognitive status ( minimum performance level ) : subject must able validly complete baseline MATRICS assessment Clinical judgment investigator treatment amisulpride risperidone warrant due suboptimal clinical outcome despite previous treatment Past current intolerance amisulpride risperidone side effect judge investigator unsafe , doselimiting , likely result study discontinuation . Any contraindication amisulpride risperidone therapy indicate drug description . Presence unstable untreated medical disorder . Any history seizures seizure disorder febrile seizures childhood ; History positive hepatitis B surface antigen . Any abnormal laboratory test judge clinically significant investigator . A history significant head injury/trauma , define : A. loss consciousness ( LOC ) 1 hour B. recur seizure result head injury C. clear cognitive sequela injury D. cognitive rehabilitation follow injury Alcohol substance dependence within past 12 month abuse within past 3 month . Any subject positive urine toxicology alcohol use consider abnormal baseline . Clinically significant suicidal homicidal behavior attempt within past 6 month . Pregnant breastfeed woman Absence medically approve contraceptive method female childbearing potential . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>